Literature DB >> 21666201

Biological feasibility of measles eradication.

William J Moss1, Peter Strebel.   

Abstract

Recent progress in reducing global measles mortality has renewed interest in measles eradication. Three biological criteria are deemed important for disease eradication: (1) humans are the sole pathogen reservoir; (2) accurate diagnostic tests exist; and (3) an effective, practical intervention is available at reasonable cost. Interruption of transmission in large geographical areas for prolonged periods further supports the feasibility of eradication. Measles is thought by many experts to meet these criteria: no nonhuman reservoir is known to exist, accurate diagnostic tests are available, and attenuated measles vaccines are effective and immunogenic. Measles has been eliminated in large geographical areas, including the Americas. Measles eradication is biologically feasible. The challenges for measles eradication will be logistical, political, and financial.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21666201      PMCID： PMC3112320          DOI： 10.1093/infdis/jir065

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  46 in total

1.  Progress in global measles control and mortality reduction, 2000-2006.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2007-11-30

2.  Genetic variability of measles virus in acute and persistent infections.

Authors:  Mirjam Kühne; David W G Brown; Li Jin
Journal:  Infect Genet Evol       Date:  2005-09-19       Impact factor: 3.342

3.  Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States.

Authors:  Amy A Parker; Wayne Staggs; Gustavo H Dayan; Ismael R Ortega-Sánchez; Paul A Rota; Luis Lowe; Patricia Boardman; Robert Teclaw; Charlene Graves; Charles W LeBaron
Journal:  N Engl J Med       Date:  2006-08-03       Impact factor: 91.245

4.  Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.

Authors:  Inna G Ovsyannikova; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2006-01-27       Impact factor: 5.226

5.  Considering human-primate transmission of measles virus through the prism of risk analysis.

Authors:  Lisa Jones-Engel; Gregory A Engel; Michael A Schillaci; Benjamin Lee; John Heidrich; Mukesh Chalise; Randall C Kyes
Journal:  Am J Primatol       Date:  2006-09       Impact factor: 2.371

6.  Subacute sclerosing panencephalitis: more cases of this fatal disease are prevented by measles immunization than was previously recognized.

Authors:  William J Bellini; Jennifer S Rota; Luis E Lowe; Russell S Katz; Paul R Dyken; Sherif R Zaki; Wun-Ju Shieh; Paul A Rota
Journal:  J Infect Dis       Date:  2005-10-12       Impact factor: 5.226

7.  The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants.

Authors:  Susana Scott; William J Moss; Simon Cousens; Judy A Beeler; Susette A Audet; Nanthalile Mugala; Thomas C Quinn; Diane E Griffin; Felicity T Cutts
Journal:  Clin Infect Dis       Date:  2007-10-22       Impact factor: 9.079

Review 8.  Measles vaccines.

Authors:  Diane E Griffin; Chien-Hsiung Pan; William J Moss
Journal:  Front Biosci       Date:  2008-01-01

9.  Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.

Authors:  William J Moss; Susana Scott; Nanthalile Mugala; Zaza Ndhlovu; Judy A Beeler; Susette A Audet; Mirriam Ngala; Sheila Mwangala; Chansa Nkonga-Mwangilwa; Judith J Ryon; Mwaka Monze; Francis Kasolo; Thomas C Quinn; Simon Cousens; Diane E Griffin; Felicity T Cutts
Journal:  J Infect Dis       Date:  2007-06-19       Impact factor: 5.226

10.  Slow clearance of measles virus RNA after acute infection.

Authors:  Michaela A Riddell; William J Moss; Debra Hauer; Mwaka Monze; Diane E Griffin
Journal:  J Clin Virol       Date:  2007-07-10       Impact factor: 3.168
View more
  27 in total

1.  Independence of measles-specific humoral and cellular immune responses to vaccination.

Authors:  Robert M Jacobson; Inna G Ovsyannikova; Robert A Vierkant; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2012-03-03       Impact factor: 2.850

2.  Implication of health care personnel in measles transmission.

Authors:  Núria Torner; Ruben Solano; Cristina Rius; Angela Domínguez; The Measles Elimination Program Surveillance Network Of Catalonia Spain
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

3.  A Temperature-Dependent Translation Defect Caused by Internal Ribosome Entry Site Mutation Attenuates Foot-and-Mouth Disease Virus: Implications for Rational Vaccine Design.

Authors:  Decheng Yang; Chao Sun; Rongyuan Gao; Haiwei Wang; Wenming Liu; Kewei Yu; Guohui Zhou; Bo Zhao; Li Yu
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

4.  Measles Vaccination is Best for Children: The Argument for Relying on Herd Immunity Fails.

Authors:  Johan Christiaan Bester
Journal:  J Bioeth Inq       Date:  2017-08-16       Impact factor: 1.352

5.  The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines?

Authors:  Gregory A Poland; Robert M Jacobson
Journal:  Vaccine       Date:  2012-01-05       Impact factor: 3.641

6.  Genetically defined race, but not sex, is associated with higher humoral and cellular immune responses to measles vaccination.

Authors:  Emily A Voigt; Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Beth R Larrabee; Daniel J Schaid; Gregory A Poland
Journal:  Vaccine       Date:  2016-08-30       Impact factor: 3.641

7.  A microneedle patch containing measles vaccine is immunogenic in non-human primates.

Authors:  Chris Edens; Marcus L Collins; James L Goodson; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2015-03-12       Impact factor: 3.641

Review 8.  The genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approaches.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; V Shane Pankratz; Richard B Kennedy; Robert M Jacobson; Gregory A Poland
Journal:  Expert Rev Vaccines       Date:  2013-01       Impact factor: 5.217

9.  Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.

Authors:  Núria Torner; Andres Anton; Irene Barrabeig; Sara Lafuente; Ignasi Parron; César Arias; Neus Camps; Josep Costa; Ana Martínez; Roser Torra; Pere Godoy; Sofia Minguell; Glòria Ferrús; Carmen Cabezas; Ángela Domínguez
Journal:  Hum Vaccin Immunother       Date:  2013-01-09       Impact factor: 3.452

10.  Synonymous Deoptimization of Foot-and-Mouth Disease Virus Causes Attenuation In Vivo while Inducing a Strong Neutralizing Antibody Response.

Authors:  Fayna Diaz-San Segundo; Gisselle N Medina; Elizabeth Ramirez-Medina; Lauro Velazquez-Salinas; Marla Koster; Marvin J Grubman; Teresa de los Santos
Journal:  J Virol       Date:  2015-11-18       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.